SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending due to a significant after-hours price drop following its NHS-Galleri cancer screening trial missing its primary endpoint for statistically significant late-stage cancer detection. The community is sharply divided, with many calling the market reaction an extreme overreaction given the test's perceived utility, the company's solid financials, and its ongoing FDA approval process, while others anticipate further declines and question the test's overall effectiveness.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is surging as its all-stock acquisition of Valaris creates an offshore drilling giant with a massive backlog and anticipated synergies, driving community excitement for a potential short squeeze and significant re-rating in a robust energy market.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending following a mixed market reaction to its dual financing announcement: a proposed $100 million public stock offering and a $100 million royalty funding deal with RTW Investments. While some investors express significant concern over dilution, others view the combined capital as a strategic move to secure a robust runway for its advanced pipeline and upcoming BLA submission, enhancing long-term commercialization flexibility.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as a recent corporate presentation highlighted significant anticipated distribution and shelf space growth for its brands, further bolstered by positive comments from a key strategic partner regarding collaboration and market execution. While many in the community are optimistic about continued sales expansion, others express frustration over recent stock volatility and perceived management communication challenges.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is gaining significant attention amid strong rumors of a potential partnership with OpenAI to monetize ChatGPT through ads, fueling investor excitement and a desire for a short squeeze. This speculation comes as the community debates the stock's recent sharp decline, which many view as an unjustified overreaction to broader AI disruption fears, given the company's robust earnings and advanced AI ad-tech.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending following its recent revenue growth and the significant extension of its IBSRELA and XPHOZAH patent protection into 2042, fueling community debate on long-term value creation through increased development spending versus immediate profitability, alongside continued speculation about potential strategic partnerships.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna (KLAR) is experiencing extreme volatility and trending heavily after its latest earnings report revealed robust revenue growth and expanding user base, especially in the US, but also a net loss driven by a significant increase in loan loss provisions. The community is sharply divided, with many calling the 'buy now, pay later' business model unsustainable and predicting further declines, while others view the sell-off as an 'overreaction' and a prime buying opportunity, citing strong underlying growth and strategic partnerships.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending after beating Q4 expectations with strong e-commerce and advertising growth, coupled with a new $30 billion share repurchase program. However, community discussion is split, with bulls highlighting digital strength and capital return, while bears express concern over conservative FY27 guidance and the stock's elevated valuation.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont Corp is trending following an earnings beat that surpassed revenue and EPS expectations, yet its stock performance is mixed as the community debates a more conservative 2026 production outlook. Despite strong financial results and a bullish sentiment around gold's record prices, investors are weighing future output guidance against the company's current performance and the broader precious metals rally.

AIOS Foundation

AIOS is trending due to its recent ticker change from NISN and a substantial after-hours volume surge, sparking widespread community discussion about its potential for a 'gap fill' setup as a 'China penny play,' despite some expressing caution regarding its financial history and recent private placement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sio Gene Therapies, formerly known as Axovant, is a clinical-stage company with a singular focus on pushing the boundaries of gene therapy to develop treatments for debilitating neurodegenerative diseases, including GM1 gangliosidosis, Tay-Sachs/Sandhoff disease, and Parkinsonâ??s disease. Sio is leveraging its foundational scientific expertise built on decades of research, extensive collaborations with leading gene therapy institutes, and a flexible vector platform to liberate patients with debilitating diseases through the transformational power of gene therapies.

AXGT
Axovant Sciences

Feed

News

Sentiment

Fundamentals

Info

Latest AXGT News

AXGTAxovant Sciences